Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,356,331
  • Shares Outstanding, K 52,449
  • Annual Sales, $ 408,900 K
  • Annual Income, $ 110,990 K
  • 60-Month Beta 1.61
  • Price/Sales 3.23
  • Price/Cash Flow 10.28
  • Price/Book 2.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.59
  • Number of Estimates 4
  • High Estimate 0.64
  • Low Estimate 0.53
  • Prior Year 0.52
  • Growth Rate Est. (year over year) +13.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.15 +2.82%
on 10/10/19
29.81 -13.25%
on 09/19/19
-2.72 (-9.52%)
since 09/11/19
3-Month
25.15 +2.82%
on 10/10/19
34.11 -24.19%
on 07/31/19
-6.12 (-19.14%)
since 07/11/19
52-Week
25.15 +2.82%
on 10/10/19
49.47 -47.73%
on 10/18/18
-21.74 (-45.67%)
since 10/11/18

Most Recent Stories

More News
Supernus to Present at the 2019 Cantor Global Healthcare Conference

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the...

SUPN : 25.86 (+2.54%)
Pacira Pharmaceu has the Best Relative Performance in the Pharmaceuticals Industry (PCRX , SUPN , HZNP , ZTS , JNJ )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

HZNP : 27.06 (+2.73%)
PCRX : 37.69 (+2.50%)
SUPN : 25.86 (+2.54%)
After Yesterday's Decline of 4.59%, Supernus Pharmac Offers Investors Better Value

Supernus Pharmac (NASDAQ:SUPN) traded in a range yesterday that spanned from a low of $28.03 to a high of $29.06. Yesterday, the shares fell 4.6%, which took the trading range below the 3-day low of...

SUPN : 25.86 (+2.54%)
15.0% Return Seen to Date on SmarTrend Supernus Pharmac Call (SUPN)

SmarTrend identified a Downtrend for Supernus Pharmac (NASDAQ:SUPN) on May 8th, 2019 at $34.33. In approximately 4 months, Supernus Pharmac has returned 15.02% as of today's recent price of $29.17.

SUPN : 25.86 (+2.54%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (RVNC , SUPN , HZNP , LCI , ZGNX )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

HZNP : 27.06 (+2.73%)
RVNC : 12.18 (+4.46%)
SUPN : 25.86 (+2.54%)
Supernus Pharmac Down 16.7% Since SmarTrend Downtrend Call (SUPN)

SmarTrend identified a Downtrend for Supernus Pharmac (NASDAQ:SUPN) on May 8th, 2019 at $34.33. In approximately 4 months, Supernus Pharmac has returned 16.74% as of today's recent price of $28.58.

SUPN : 25.86 (+2.54%)
Supernus Pharmac Down 21.0% Since SmarTrend Downtrend Call (SUPN)

SmarTrend identified a Downtrend for Supernus Pharmac (NASDAQ:SUPN) on May 8th, 2019 at $34.33. In approximately 4 months, Supernus Pharmac has returned 21.05% as of today's recent price of $27.10.

SUPN : 25.86 (+2.54%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Supernus Pharmac (SUPN , NKTR , PRGO , MYL , MDCO )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

NKTR : 17.09 (+5.95%)
PRGO : 53.44 (+2.77%)
SUPN : 25.86 (+2.54%)
Supernus Pharmac Down 25.8% Since SmarTrend Downtrend Call (SUPN)

SmarTrend identified a Downtrend for Supernus Pharmac (NASDAQ:SUPN) on May 8th, 2019 at $34.33. In approximately 4 months, Supernus Pharmac has returned 25.80% as of today's recent price of $25.47.

SUPN : 25.86 (+2.54%)
Supernus to Present at Two September Healthcare Conferences

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the...

SUPN : 25.86 (+2.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade SUPN with:

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

2nd Resistance Point 26.79
1st Resistance Point 26.33
Last Price 25.86
1st Support Level 25.41
2nd Support Level 24.95

See More

52-Week High 49.47
Fibonacci 61.8% 40.18
Fibonacci 50% 37.31
Fibonacci 38.2% 34.44
Last Price 25.86
52-Week Low 25.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar